Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2014
06/17/2014US8754226 Piperidinyl-substituted lactams as GPR119 modulators
06/17/2014US8754225 Process for preparing a biphenyl-2-ylcarbamic acid
06/17/2014US8754221 Optically active cyclic alcohol compound and method for preparing the same
06/17/2014US8754218 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
06/17/2014US8754211 Azolotriazinone melanin concentrating hormone receptor-1 antagonists
06/17/2014US8754209 Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
06/17/2014US8754107 Aminopyrrolidines as chemokine receptor antagonists
06/17/2014US8754100 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
06/17/2014US8754095 Substituted N-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
06/17/2014US8754092 Inhibitors of the hedgehog pathway
06/17/2014CA2725014C Inhibitors of pi3 kinase
06/17/2014CA2699986C Anti-infective pyrimidines and uses thereof
06/17/2014CA2699933C Fungicidal mixtures
06/17/2014CA2644649C Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53
06/17/2014CA2630273C Heterocyclylalkyl derivatives as inhibitors of histone deacetylase
06/17/2014CA2601979C 2,3 substituted pyrazine sulfonamides
06/12/2014WO2014088519A1 Compounds including map kinase interacting kinases 1 and 2 (mnk1 and mnk2) modulators and abl and abl (t315i) inhibitors, and uses thereof
06/12/2014WO2014088300A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
06/12/2014WO2014088290A1 Organic electroluminescent compounds and organic electroluminescent device comprising the same
06/12/2014WO2014088085A1 Pyridone compound
06/12/2014WO2014087298A1 Novel selective androgen receptor modulators
06/12/2014WO2014087165A1 Tankyrase inhibitors
06/12/2014WO2014086964A1 New derivatives of indole for the treatment of cancer, viral infections and lung diseases
06/12/2014WO2014086894A1 Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
06/12/2014WO2014086865A1 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors
06/12/2014WO2014086855A1 Phenylethylpyridine derivatives as pde4-inhibitors
06/12/2014WO2014086852A1 Phenylethylpyridine derivatives as pde4-inhibitors
06/12/2014WO2014086849A1 Phenylethylpyridine derivatives as pde4-inhibitors
06/12/2014WO2014086807A1 Novel pyrazine derivatives as cb2 receptor agonists
06/12/2014WO2014086806A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086805A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086737A1 Condensed 2-pyridone-3-carboxamides and the use thereof as herbicides
06/12/2014WO2014086712A1 New indanyloxydihydrobenzofuranylacetic acids
06/12/2014WO2014086705A1 Novel pyridine derivatives
06/12/2014WO2014086663A1 Substituted triazole and imidazole compounds
06/12/2014WO2014086102A1 Indole full ketone derivative used as tyrosine-kinase inhibitor
06/12/2014WO2014062733A3 Substituted benzene compounds
06/12/2014WO2014047662A3 Indazole derivatives and uses thereof
06/12/2014US20140163234 Process for preparing N-substituted 1H-pyrazole-5-carbonylchloride compounds
06/12/2014US20140163232 Method of producing aromatic amino compounds
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163206 Haptens of aripiprazole
06/12/2014US20140163075 Modulation of the ubiquitin-proteasome system (ups)
06/12/2014US20140163073 Small Molecule Inhibitors of P-type ATPases
06/12/2014US20140163069 Compositions of targeted drug development
06/12/2014US20140163055 Methods and compositions of treating hiv infection
06/12/2014US20140163036 Carbamate/urea derivatives
06/12/2014US20140163032 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
06/12/2014US20140163024 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS
06/12/2014US20140163009 Histone deacetylase inhibitors and compositions and methods of use thereof
06/12/2014US20140162997 Substituted pyrazoles as n-type calcium channel blockers
06/12/2014US20140162985 Heterocyclic nuclear hormone receptor modulators
06/12/2014US20140162984 Phosphonoxy quinazoline derivatives and their pharmaceutical use
06/12/2014US20140162983 Compositions and Methods for the Production of Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity
06/12/2014US20140162874 Pesticidal compositions and processes related thereto
06/12/2014US20140162361 Pyrimidine cyclohexyl glucocorticoid receptor modulators
06/12/2014US20140161801 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
06/12/2014US20140161729 Cofluorons and methods of making and using them
06/11/2014EP2740728A1 Uracil derivative and use thereof for medical purposes
06/11/2014EP2740477A1 Method for treating cancer by combined use of medicinal agents
06/11/2014EP2739617A1 Spirocyclic molecules as protein kinase inhibitors
06/11/2014EP2739616A1 Pyridin-2(1h)-one derivatives as jak inhibitors
06/11/2014EP2739615A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
06/11/2014EP2739611A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
06/11/2014CN103857737A Stabilizing of organic material with amino-triazine based mannich-compounds
06/11/2014CN103857675A Metalloenzyme inhibitor compounds
06/11/2014CN103857672A Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
06/11/2014CN103857671A New benzotriazole derivative and organic electroluminescent element in which said derivative is used
06/11/2014CN103857670A 2-oxo-piperidinyl derivatives
06/11/2014CN103857669A Methods of producing anamorelin hydrochloride having controlled chloride content
06/11/2014CN103857668A Ethynyl derivatives as mglur5 allosteric modulators
06/11/2014CN103857666A N-thio-anthranilamide compounds and their use as pesticides
06/11/2014CN103848829A Heteroaryl alkyne compounds and application thereof
06/11/2014CN103848822A 1,8-carbazole derivative, preparation method and application thereof in luminescent device
06/11/2014CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition
06/11/2014CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs
06/11/2014CN103848819A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition in drugs
06/11/2014CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs
06/11/2014CN103848815A 4-substituent-6-phenyl pyrimidine derivatives comprising carbamido fragments and preparation method and use of derivatives
06/11/2014CN103848814A Substituted indole ketone derivative as tyrosine kinase inhibitor
06/11/2014CN103848813A Preparation method of imatinib
06/11/2014CN103848812A Method of refining imatinib
06/11/2014CN103848811A Uracil derivative, preparation method and application thereof
06/11/2014CN103848810A Bruton's tyrosine kinases inhibitor
06/11/2014CN103848792A 4,4-disubstituted-dihydro-2-(1H)-quinazolinone as well as synthetic method and use thereof
06/11/2014CN103848785A Perylene 3-cyano quinoline compound, medicinal compound, and preparation method and use thereof
06/11/2014CN103848782A Application of compound to preparation of drugs for treating glaucoma
06/11/2014CN103848767A Synthetic method of aryl thioether compound
06/11/2014CN103254174B Lansoprazole compound and pharmaceutical composition thereof
06/11/2014CN102947289B Arylethynyl derivatives
06/11/2014CN102863380B Preparation method of 1-alkynyl-2-aryl-1,2,3,4-tetrahydroisoquinoline compound
06/11/2014CN102718747B Olprinone hydrochloride derivate and synthetic method thereof
06/11/2014CN102596936B Antiviral compounds
06/11/2014CN102584792B Method for preparing high-purity esomeprazole
06/11/2014CN102491987B 1,10-phenanthroline hydrate functionalized N-heterocyclic carbene and tetranuclear copper compound and preparation method for same
06/11/2014CN102405217B Azaazulene compounds
06/11/2014CN102256963B Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/11/2014CN102066356B Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
06/11/2014CN101932573B Novel pyridinones and pyridazinones
06/11/2014CN101595100B Heterocyclic-substituted piperidine as orl-1 ligands
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 1080